Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening
- PMID: 11809259
- DOI: 10.1016/s0140-6736(02)07339-7
Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening
Abstract
We investigated the relation between positivity for hepatitis C virus (HCV) and carotid-artery plaque and carotid intima-media thickening by analysing cross-sectional data of individuals undergoing a general health screening test. Of 4784 individuals enrolled, 104 (2.2%) were seropositive for HCV. After adjustment for confounding risk factors, HCV seropositivity was found to be associated with an increased risk of carotid-artery plaque (odds ratio 1.92 [95% CI 1.56-2.38], p=0.002) and carotid intima-media thickening (2.85 [2.28-3.57], p<0.0001). These findings suggest a possible role for chronic hepatitis C in the pathogenesis of carotid arterial remodelling.
Similar articles
-
Association between chronic kidney disease and carotid intima-media thickening in individuals with hypertension and impaired glucose metabolism.Hypertens Res. 2007 Nov;30(11):1035-41. doi: 10.1291/hypres.30.1035. Hypertens Res. 2007. PMID: 18250552
-
Differing effect of modifiable cardiovascular risk factors on intima-media thickening and plaque formation at different sites of the arterial vasculature.Heart. 2010 Oct;96(19):1579-85. doi: 10.1136/hrt.2009.188219. Epub 2010 Aug 11. Heart. 2010. PMID: 20702541
-
Relation of aortic valve sclerosis to carotid artery intima-media thickening in healthy subjects.Am J Cardiol. 2004 Sep 15;94(6):837-9. doi: 10.1016/j.amjcard.2004.06.015. Am J Cardiol. 2004. PMID: 15374806
-
[Common carotid artery intima-media thickness: the role in evaluation of atherosclerosis progression].Neurol Neurochir Pol. 2001 Nov-Dec;35(6):1093-102. Neurol Neurochir Pol. 2001. PMID: 11987705 Review. Polish.
-
The intima : A new soil.Circ Res. 1999 Nov 12;85(10):877-9. doi: 10.1161/01.res.85.10.877. Circ Res. 1999. PMID: 10559132 Review. No abstract available.
Cited by
-
Cardioprotective effect of antiviral therapy among hepatitis C infected patients: A meta-analysis.Int J Cardiol Heart Vasc. 2023 Sep 22;49:101270. doi: 10.1016/j.ijcha.2023.101270. eCollection 2023 Dec. Int J Cardiol Heart Vasc. 2023. PMID: 37766883 Free PMC article.
-
Metabolic factors and chronic hepatitis C: a complex interplay.Biomed Res Int. 2013;2013:564645. doi: 10.1155/2013/564645. Epub 2013 Jul 17. Biomed Res Int. 2013. PMID: 23956991 Free PMC article. Review.
-
Hepatitis C virus and cardiovascular: A review.J Adv Res. 2017 Mar;8(2):161-168. doi: 10.1016/j.jare.2016.06.001. Epub 2016 Jun 18. J Adv Res. 2017. PMID: 28149651 Free PMC article. Review.
-
Performance of the Pooled Cohort atherosclerotic cardiovascular disease risk score in hepatitis C virus-infected persons.J Viral Hepat. 2017 Oct;24(10):814-822. doi: 10.1111/jvh.12705. Epub 2017 Apr 10. J Viral Hepat. 2017. PMID: 28273386 Free PMC article.
-
Short Communication: Coronary Heart Disease Risk by Framingham Risk Score in Hepatitis C and HIV/Hepatitis C-Coinfected Persons.AIDS Res Hum Retroviruses. 2015 Jul;31(7):718-22. doi: 10.1089/AID.2014.0284. Epub 2015 May 11. AIDS Res Hum Retroviruses. 2015. PMID: 25858663 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical